The PNC Financial Services Group, Inc. (PNC) continued its downward trend with the stock declining -0.01% or $-0.01 to close the day at $121.46 on light trading volume of 2.89M shares, compared to its three month average trading volume of 3.08M. The Pittsburgh Pennsylvania 15222 based company has been outperforming the money center banks group over the past 52 weeks, with the stock gaining 51.28%, compared to the industry which has advanced 25.8% over the same period. With RSI of 58.2, the stock should still continue to rise and get closer to its one year target estimate of $124.38, making it a hold for now.
The PNC Financial Services Group, Inc. operates as a diversified financial services company in the United States and internationally. The company’s Retail Banking segment offers deposit, lending, brokerage, investment management, and cash management services to consumer and small business customers through branch network, ATMs, call centers, online banking, and mobile channels. As of March 31, 2016, this segment operated a network of 2,613 branches and 8,940 ATMs. Its Corporate & Institutional Banking segment provides secured and unsecured loans, letters of credit, equipment leases, cash and investment management, receivables management, disbursement and funds transfer, information reporting, trade services, foreign exchange, derivatives, securities, loan syndications, mergers and acquisitions advisory, equity capital markets advisory, and related services for corporations, government, and not-for-profit entities. This segment also offers commercial loan servicing, and real estate advisory and technology solutions for the commercial real estate finance industry. The company’s Asset Management Group segment provides investment and retirement planning, customized investment management, private banking, tailored credit solutions, and trust management and administration for individuals and their families; multi-generational family planning products; and mutual funds and institutional asset management services. Its Residential Mortgage Banking segment offers first lien residential mortgage loans. The company’s BlackRock segment provides investment and risk management services to institutional and retail clients. Its Non-Strategic Assets Portfolio segment offers consumer residential mortgage, brokered home equity loans, and lines of credit, as well as commercial real estate loans and leases. The PNC Financial Services Group, Inc. was founded in 1922 and is headquartered in Pittsburgh, Pennsylvania.
CA, Inc. (CA) retreated with the stock falling -0.48% or $-0.15 to close at $31.34 on active trading volume of 2.88M compared its three months average trading volume of 2.69M. The New York New York 10022 based company operating under the Business Software & Services industry has been trending up for the last 52 weeks, with the shares price now 17.49% up for the period and down by -1.35% so far this year. With price target of $32.8 and a 20.59% rebound from 52-week low, CA, Inc. has plenty of upside potential, making it a hold with a view buy.
CA, Inc. provides information technology (IT) management software and solutions that help organizations plan, develop, manage, and secure applications and IT infrastructure in the United States and internationally. The company operates through three segments: Mainframe Solutions, Enterprise Solutions, and Services. The Mainframe Solutions segment’s products portfolio include databases and database management, systems and operations management, application development, and security and compliance. The Enterprise Solutions segment provides products that are designed for distributed and cloud computing environments and run on industry standard servers. It offers Agile management solutions, which enables customers to plan and manage software development process and IT services delivery; DevOps solutions comprising a range of solutions that allow customers to deliver and manage applications and IT infrastructure; and security solutions, such as identity-centric security portfolio that allows customers to manage identities and regulate access from the device to the data center. The Services segment offers consulting, implementation, application management services, education, and support services to commercial and government customers. The company serves banks, insurance companies, other financial services providers, government agencies, global service providers, telecommunication providers, manufacturers, technology companies, retailers, educational organizations, and health care institutions. CA, Inc. sells its solutions through direct sales force, as well as indirectly through its partners. The company was formerly known as CA Technologies and changed its name to CA, Inc. in 2006. CA, Inc. was founded in 1974 and is headquartered in New York, New York.
Zoetis Inc. (ZTS) failed to extend gains with the stock declining -0.04% or $-0.02 to close the day at $55.96 on lower than average trading volume of 2.88M shares, compared to its three month average trading volume of 3.01M. The Florham Park New Jersey 07932 based company has been outperforming the drugs – generic companies by 12.0384% for last three months and its recent gains have pushed the stock slightly up 4.75% YTD, versus the drugs – generic industry which is up 9.7% for the same period. The RSI of 71.87 indicates the stock is overbought at the current levels, sell for now.
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines and vaccines for livestock and companion animals in the United States and internationally. It offers anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; and parasiticides that prevent or eliminate external and internal parasites, such as fleas, ticks, and worms. The company also provides medicated feed additives that offer medicines to livestock; veterinarian solutions for anesthesia, pain management, and the diagnosis of diabetes; and other pharmaceutical products, including pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products. In addition, it offers other product categories comprising nutritionals and agribusiness services, as well as products and services in complementary areas consisting of biodevices, diagnostics, and genetics. The company markets its products to veterinarians and livestock producers through its sales representatives, and technical and veterinary operations specialists. Zoetis Inc. was founded in 1952 and is headquartered in Florham Park, New Jersey.